AML (ACUTE MYELOGENOUS LEUKEMIA)
Clinical trials for AML (ACUTE MYELOGENOUS LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new AML (ACUTE MYELOGENOUS LEUKEMIA) trials appear
Sign up with your email to follow new studies for AML (ACUTE MYELOGENOUS LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with down syndrome and leukemia: gentler chemo shows promise
Disease control Recruiting nowThis study tests a chemotherapy plan designed specifically for children (0-18 years) with acute myeloid leukemia (AML) and Down syndrome. The goal is to improve survival while reducing harsh side effects by using lower drug doses. About 100 children in Russia will receive four ro…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE3 • Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
Can a broccoli compound revive old cord blood transplants? new study aims to find out.
Disease control Recruiting nowThis study tests whether a dietary supplement called sulforaphane (found in broccoli) can safely help blood cell recovery in adults receiving a cord blood transplant for blood cancers like leukemia or myelodysplastic syndrome. The cord blood used has been frozen for 10 years or m…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New combo aims to match AML patients with the right treatment
Disease control Recruiting nowThis study tests whether adding the targeted drug venetoclax to standard intensive chemotherapy improves outcomes for adults with acute myeloid leukemia (AML). The goal is to find out which genetic subtypes of AML respond best to this combination. About 380 participants aged 14 t…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for tough blood cancers: experimental drug CG009301 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called CG009301 in adults with blood cancers (like leukemia or MDS) that returned or didn't respond to standard treatments. The main goals are to find a safe dose and check for side effects. About 45 participants will receive the drug until…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug cocktails aim to tame transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests new drug combinations to prevent graft-versus-host disease (GVHD) in people with blood cancers who receive stem cells from an unrelated donor. About 358 participants will get either the standard GVHD prevention drugs or a new mix, and researchers will compare whi…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Blood test may predict drug side effects in leukemia patients
Knowledge-focused Recruiting nowThis study looks at whether the amount of venetoclax in the blood is linked to serious side effects in people with acute myeloid leukemia (AML) who are in remission. Researchers will measure drug levels in 14 patients and track how often severe low white blood cell counts occur. …
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC